Biology Reference
In-Depth Information
Legendre C, Gras G, Krzysiek R, Galanaud P, Richard Y, Dormont D. 1996. Mechanisms of
opsonized HIV entry in normal B lymphocytes. FEBS Lett 381: 227±232.
Legendre C, Raphael M, Gras G, Lefevre EA, Feuillard J, Dormont D, Richard Y. 1998. CD80
expression is decreased in hyperplastic lymph nodes of HIV
patients. Int Immunol 10: 1847±
1851.
Liu YJ. 1997. Sites of B lymphocyte selection, activation, and tolerance in spleen. J Exp Med 186:
625±629.
Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. 1989. Mechanism of
antigen-driven selection in germinal centres. Nature 342: 929±931.
Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. 1991. Sites of speci®c B cell activation in
primary and secondary responses to T cell-dependent and T cell-independent antigens [published
erratum appears in Eur J Immunol 1992; 22: 615]. Eur J Immunol 21: 2951±2962.
Liu YJ, Johnson GD, Gordon J, MacLennan IC. 1992. Germinal centres in T-cell-dependent anti-
body responses. Immunol Today 13: 17±21.
Liu YJ, de Bouteiller O, Arpin C, Durand I, Banchereau J. 1994. Five human mature B cell subsets.
Adv Exp Med Biol 355: 289±296.
Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. 2000. BLC expression in pancreatic islets causes
B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12: 471±481.
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA.
1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in
CXCR4- and SDF-1-de®cient mice. Proc Natl Acad Sci USA 95: 9448±9453.
Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. 1993. Membrane
tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-
infected human T cells. Nature 363: 464±466.
Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. 1987. Infection with the human
immunode®ciency virus (HIV) associated with an in vivo increase in B lymphocyte activation
and immunity. J Immunol 138: 3720.
Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu YJ. 1996. Human ger-
minal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the
survival gene bcl-2. J Exp Med 183: 971±977.
Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT. 1991. Inter-
section of the complement and immune systems: a signal transduction complex of the B lym-
phocyte-containing complement receptor type 2 and CD19. J Exp Med 173: 55±64.
McHeyzer-Williams MG, McLean MJ, Lalor PA, Nossal GJ. 1993. Antigen-driven B cell di¨er-
entiation in vivo. J Exp Med 178: 295±307.
Melchers F, Rolink AG, Schaniel C. 1999. The role of chemokines in regulating cell migration
during humoral immune responses. Cell 99: 351±354.
Moir S, Lapointe R, Malaspina A, Ostrowski M, Cole CE, Chun TW, Adelsberger J, Baseler M,
Hwu P, Fauci AS. 1999. CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes
correlates with restricted susceptibility to human immunode®ciency virus type 1 infection:
potential role of B lymphocytes as a viral reservoir. J Virol 73: 7972±7980.
Morris L, Binley JM, Clas BA, Bonhoe¨er S, Astill TP, Kost R, Hurley A, Cao Y, Markowitz M,
Ho DD, Moore JP. 1998. HIV-1 antigen-speci®c and -nonspeci®c B cell responses are sensitive
to combination antiretroviral therapy. J Exp Med 188: 233±245.
Neshat MN, Goodglick L, Lim K, Braun J. 2000. Mapping the B cell superantigen binding site for
HIV-1 gp120 on a V( H)3 Ig. Int Immunol 12: 305±312.
Ng VL, McGrath MS. 1998. The immunology of AIDS-associated lymphomas. Immunol Rev 162:
293±298.
Ng VL, Hurt MH, Fein CL, Khayam-Bashi F, Marsh J, Nunes WM, McPhaul LW, Feigal E,
Nelson P, Herndier BG, et al. 1994. IgMs produced by two acquired immune de®ciency syn-
